Cardioprotective Effect of the F-36 Alkaloid and DKV-8 Conjugate
Litsenziya: cc-by-nc-nd
Annotatsiya
The search for new therapeutic strategies for cardiovascular diseases remains an urgent issue. This study investigated the effects of the natural compound 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (F-36) and its conjugate with dihydroquercetin, DKV-8, on the contractile activity of rat heart papillary muscle and their molecular mechanisms. In vitro mechanographic experiments showed that F-36 (5 - 100 µM) and DKV-8 (5 - 40 µM) dose-dependently increased contraction force by 75.7 ± 4.7 and 143.6 ± 5.4%, respectively. studies using specific inhibitors (lidocaine, nifedipine, NiCl₂, caffeine, and cyclopiazonic acid (CPA)) demonstrated that Na⁺ channels, L-type Ca²⁺ channels, and sarcoplasmic reticulum Ca²⁺-ATPase (SERCA2a) play a key role in the observed positive inotropic effect. Overall, F-36 and its DKV-8 conjugate enhance cardiomyocyte Ca²⁺ homeostasis mainly through regulation of SERCA2a and plasma membrane ion channels. Their effects were also confirmed under in vitro hypoxic conditions. HIGHLIGHTS F-36 alkaloid and its DHQ-based conjugate DKV-8 produce a pronounced positive inotropic effect in isolated rat cardiac papillary muscle. The inotropic action is mediated by coordinated activation of Na⁺ and L-type Ca²⁺ channels, leading to increased intracellular Ca²⁺ availability. SERCA2a activation is a key mechanism underlying enhanced sarcoplasmic reticulum Ca²⁺ accumulation and stronger myocardial contraction. NCX and excessive RyR2 activation are not critically involved, indicating a selective and controlled Ca²⁺ regulation. This balanced modulation of Ca²⁺ homeostasis suggests low arrhythmogenic risk and highlights DKV-8 as a promising cardiotonic candidate. DKV-8 conjugate activates SERCA2a to a significant extent. GRAPHICAL ABSTRACT
Hali tarjima qilinmagan